Superparamagnetic iron oxide nanoparticles conjugated with Aβ oligomer-specific scFv antibody and class A scavenger receptor activator show therapeutic potentials for Alzheimer’s Disease

Superparamagnetic iron oxide nanoparticles conjugated with Aβ oligomer-specific scFv antibody and class A scavenger receptor activator show therapeutic potentials for Alzheimer’s Disease

Abstract Background Alzheimer’s disease (AD) is a progressive neurodegenerative disorder. No disease-modifying strategy to prevent or delay AD progression currently exists. Aβ oligomers (AβOs), rather than monomers or fibrils, are considered as the primary neurotoxic species. Therapeutic approaches...

Full description

Bibliographic Details
Main Authors: Xiao-ge Liu, Lun Zhang, Shuai Lu, Dong-qun Liu, Ya-ru Huang, Jie Zhu, Wei-wei Zhou, Xiao-lin Yu, Rui-tian Liu
Format: Article
Language:English
Published: BMC 2020-11-01
Series:Journal of Nanobiotechnology
Subjects:
Alzheimer’s disease
β-Amyloid
Oligomer
Class A scavenger receptor
Therapy
Online Access:http://link.springer.com/article/10.1186/s12951-020-00723-1

Internet

http://link.springer.com/article/10.1186/s12951-020-00723-1

Similar Items